SEB Concept Biotechnology - Klasse D (EUR)
LU0118405827
SEB Concept Biotechnology - Klasse D (EUR)/ LU0118405827 /
| NAV26/06/2024 |
Var.-1.6220 |
Type of yield |
Focus sugli investimenti |
Società d'investimento |
| 112.0180EUR |
-1.43% |
paying dividend |
Equity
Worldwide
|
SEB IM ▶ |
Investment strategy
The fund aims to increase the value of your investment over time and to outperform its benchmark.
The fund is actively managed and invests in stocks globally, primarily in the biotech sector. Investment decisions are based on in-depth (fundamental) analysis. The focus is on companies' business models, earning capacity, management and market positions. The return is determined by how much the fund's holdings increase or decrease in value during your holding period.
Investment goal
The fund aims to increase the value of your investment over time and to outperform its benchmark.
Dati master
| Type of yield: |
paying dividend |
| Fondi Categoria: |
Equity |
| Region: |
Worldwide |
| Settore: |
Sector Biotechnology |
| Benchmark: |
Nasdaq Biotechnology Index |
| Business year start: |
01/01 |
| Ultima distribuzione: |
23/05/2024 |
| Banca depositaria: |
Skandinaviska Enskilda Banken AB, Lux |
| Domicilio del fondo: |
Luxembourg |
| Permesso di distribuzione: |
Germany, Luxembourg |
| Gestore del fondo: |
Angelica Fatouros |
| Volume del fondo: |
142.53 mill.
EUR
|
| Data di lancio: |
16/10/2000 |
| Investment focus: |
- |
Condizioni
| Sovrapprezzo emissione: |
0.00% |
| Tassa amministrativa massima: |
1.50% |
| Investimento minimo: |
- EUR |
| Deposit fees: |
- |
| Redemption charge: |
0.00% |
| Prospetto semplificato: |
Download (Print version) |
Società d'investimento
| Funds company: |
SEB IM |
| Indirizzo: |
Stephanstraße 14 - 16, 60313, Frankfurt am Main |
| Paese: |
Germany |
| Internet: |
seb.de/asset-management
|
Paesi
| United States of America |
|
77.06% |
| United Kingdom |
|
7.34% |
| Sweden |
|
4.19% |
| Netherlands |
|
2.32% |
| Cash |
|
2.25% |
| Denmark |
|
2.24% |
| Ireland |
|
1.51% |
| Bermuda |
|
1.37% |
| Canada |
|
1.02% |
| Cayman Islands |
|
0.70% |
Filiali
| Pharma/Biotechnology |
|
91.82% |
| Healthcare services |
|
3.63% |
| Healthcare appliances |
|
2.30% |
| Cash |
|
2.25% |
